These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6235889)

  • 1. Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity.
    Mann JS; Howarth PH; Holgate ST
    Br Med J (Clin Res Ed); 1984 Aug; 289(6443):469. PubMed ID: 6235889
    [No Abstract]   [Full Text] [Related]  

  • 2. Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity.
    Dewhurst JK
    Br Med J (Clin Res Ed); 1984 Sep; 289(6448):833. PubMed ID: 6236871
    [No Abstract]   [Full Text] [Related]  

  • 3. Bronchoconstriction in response to ipratropium bromide.
    Patel KR; Tullett WM
    Br Med J (Clin Res Ed); 1983 Apr; 286(6374):1318. PubMed ID: 6220756
    [No Abstract]   [Full Text] [Related]  

  • 4. Bronchoconstriction induced by nebulised ipratropium bromide: relation to the bromide ion.
    Rafferty P; Beasley R; Howarth PH; Mann JS; Holgate ST
    Br Med J (Clin Res Ed); 1986 Dec; 293(6561):1538-9. PubMed ID: 2948611
    [No Abstract]   [Full Text] [Related]  

  • 5. Bronchoconstriction in response to ipratropium bromide.
    Howarth PH
    Br Med J (Clin Res Ed); 1983 Jun; 286(6380):1825-6. PubMed ID: 6222779
    [No Abstract]   [Full Text] [Related]  

  • 6. Airways responses to ipratropium bromide do not vary with time in asthmatic subjects. Studies of interindividual and intraindividual variation of bronchodilatation and protection against histamine-induced bronchoconstriction.
    Ihre E; Larsson K
    Chest; 1990 Jan; 97(1):46-51. PubMed ID: 2136826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reaction to ipratropium bromide.
    Jolobe OM
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1425-6. PubMed ID: 6215970
    [No Abstract]   [Full Text] [Related]  

  • 9. Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution.
    Beasley CR; Rafferty P; Holgate ST
    Br Med J (Clin Res Ed); 1987 May; 294(6581):1197-8. PubMed ID: 2954609
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of oxitropium bromide and ipratropium bromide in asthma.
    Peel ET; Anderson G; Cheong B; Broderick N
    Eur J Respir Dis; 1984 Feb; 65(2):106-8. PubMed ID: 6230249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ipratropium bromide in asthma. Results of a multi-clinic study.
    Storms WW; Bodman SF; Nathan RA; Busse WW; Bush RK; Falliers CJ; O'Hollaren JD; Weg JG
    Am J Med; 1986 Nov; 81(5A):61-6. PubMed ID: 2947462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reaction to ipratropium bromide.
    Connolly CK
    Br Med J (Clin Res Ed); 1982 Oct; 285(6346):934-5. PubMed ID: 6214296
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma.
    Miszkiel KA; Beasley R; Holgate ST
    Br J Clin Pharmacol; 1988 Sep; 26(3):295-301. PubMed ID: 2972308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Atrovent.
    Lichterfeld A
    Scand J Respir Dis Suppl; 1979; 103():143-7. PubMed ID: 155289
    [No Abstract]   [Full Text] [Related]  

  • 15. Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study.
    Friberg S; Graff-Lonnevig V
    Ann Allergy; 1989 Feb; 62(2):131-4. PubMed ID: 2521989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of fenoterol (Berotec) and ipratropium bromide (Atrovent) alone and in combination on bronchial hyperresponsiveness in asthmatic subjects.
    Salome CM; Wright W; Sedgwick CJ; Woolcock AJ
    Prog Clin Biol Res; 1988; 263():405-19. PubMed ID: 2967977
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose response of ipratropium assessed by two methods.
    Allen CJ; Campbell AH
    Thorax; 1980 Feb; 35(2):137-9. PubMed ID: 6445607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term ipratropium bromide nebuliser therapy and lung mucociliary clearance.
    Pavia D; Lopez-Vidriero MT; Sutton PP; Clarke SW
    Lancet; 1982 Aug; 2(8293):332-3. PubMed ID: 6124744
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bronchoconstriction and resuscitation worsened by the aerosol-- Atrovent].
    Kotaniemi J; Uutela T; Sakaranaho P
    Duodecim; 1989; 105(1):55-7. PubMed ID: 2522038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.